Skip to content
The Policy VaultThe Policy Vault

RanexaMedica

chronic angina

Preferred products

  • generic ranolazine extended-release tablets

Initial criteria

  • Patient has tried generic ranolazine extended-release tablets (Step 1 Product) within the 130-day look-back period; OR
  • For Aspruzyo Sprinkle only, patient requires administration by nasogastric or gastrostomy/gastric tube; OR
  • For Aspruzyo Sprinkle only, patient is unable to swallow or has difficulty swallowing tablets or capsules

Approval duration

1 year